Articles tagged with Antibodies
A recent study has revealed a connection between FAP, a protein involved in tadpole tail resorption, and accelerated tumor growth in humans. Researchers found that producing high levels of FAP in the tumor microenvironment promotes cancer growth. The study also explores the potential use of antibodies to block FAP's action.
Scientists have found a possible way to rescue damaged neurons from death by targeting a specific protein. The research, published in the Proceedings of the National Academy of Sciences, suggests that a proNGF antibody can prevent the interaction between two cellular proteins that cause neuron damage.
A DNA vaccine has been shown to protect against anthrax, with the protective antigen (PA)-based vaccine proving more effective than the lethal factor (LF)-based vaccine. The study found that immunization with PA induces antibodies capable of neutralizing toxin and conferring protection.
Roald Hoffmann highlights the overlooked scientific achievements of his wife, Marie-Anne Pierrette Paulze Lavoisier, and her husband Antoine Lavoisier. The collection at Cornell University provides insight into their lives and work.
A new study suggests that maternal circulating cells can migrate to the heart of infants, potentially causing a damaging immune response. The research, led by Dr. Anne Stevens, found that these cells were present at higher levels in the hearts of babies with neonatal lupus syndrome, which can cause severe heart damage.
Researchers detected 'atheronals', toxic compounds triggered by ozone in atherosclerotic plaques, suggesting a potential diagnostic marker for late-stage arterial inflammation. Ozone's role in human biology and its implications on diseases like lupus, multiple sclerosis, and rheumatoid arthritis are also explored.
A study found that four paleontologists developed acute illness after returning from expeditions in Mongolia, with antibodies detected in their blood. The risk of acquiring North Asian tick typhus is unknown during travel to endemic regions, and travelers should be suspected of having the disease even without a recognized tick bite.
Patients developing neutralizing antibodies had longer time to first relapse and increased yearly relapse rate compared to antibody-negative patients. The presence of antibodies did not affect overall disease outcome, but prompt consideration for alternative treatments may be necessary.
Researchers at UCSD investigate human dietary absorption of a cell-surface molecular sugar called N-glycolylneuraminic acid (Neu5Gc), found in red meat. The study reveals that people absorb and metabolize small amounts of Neu5Gc, triggering an immune response.
Hepatitis A vaccine boosters are unnecessary for healthy individuals, according to a meeting of experts; protective antibody amounts persist beyond 10 years after primary vaccination. Further investigations are needed for special patient groups.
Guideline suggests that early treatment with IVIg or plasma exchange can be beneficial for adults and children with severe, early Guillain-Barré syndrome. These treatments have been found to be equally effective in treating the condition.
The NIAID has launched a clinical trial to test an immunoglobulin product containing antibodies to West Nile virus (WNV) in treating severe WNV encephalitis. The study aims to assess the safety and efficacy of this treatment in preventing death or neurologic disability.
The Mayo Clinic team has successfully transplanted kidneys into 29 high-risk patients, achieving an 80% success rate. By filtering out antibodies from the patient's blood, they can create a less hostile environment for the donor kidney to adapt. This approach may change the fate of thousands of patients waiting for a transplant.
Researchers at Stanford Medicine developed a targeted DNA vaccine that can predict and treat autoimmune diseases like M.S. by analyzing antibody profiles. The vaccine uses tolerization to knock out harmful immune responses while leaving the rest of the system functional, offering new hope for personalized therapies.
Research suggests that cervical cancer vaccines may be less effective in women who are ovulating, due to fluctuations in antibody levels triggered by sex hormones. The study found higher antibody levels during the proliferative phase and lower levels around ovulation.
Scientists at Rice University have created a new test that can detect glycoprotein immunoglobulin G in whole blood with high sensitivity and speed. The innovation uses gold nanoshells to overcome challenges in existing immunoassays, enabling doctors to make quicker diagnoses without the need for time-consuming sample preparation.
A recent study published in the Canadian Medical Association Journal investigated the effects of a Chlorella-derived dietary supplement on immune function and influenza vaccination. The results showed no significant increase in antibody response to the flu vaccine overall, although some increase was seen in participants aged 50 to 55.
Researchers at USC successfully simulated the somatic hypermutation process in vitro, closely mirroring its natural occurrence. This breakthrough enables the development of an in vitro system that can mimic the body's immune response.
Scientists have determined the structure of the 2G12 antibody, which neutralizes HIV by binding to sugars on its surface. The antibody's unique structure could provide a template for designing an antigen that triggers the body to produce it, potentially leading to an HIV vaccine.
Jefferson scientists have developed a tobacco plant that produces human antibodies against rabies, addressing a global shortage of the treatment. The plant-based antibody is safer and less expensive than traditional methods, offering hope for millions affected by the deadly disease.
Scientists at the University of Toronto have made a breakthrough in understanding how to diagnose, treat, and potentially prevent infectious prion diseases like mad cow disease. By identifying specific amino acid sequences on abnormal prions, they were able to develop antibodies that can recognize and attack these rogue proteins.
The STAT program uses a combination of antibody tests and polymerase chain reaction (PCR) to detect acute HIV infections, which are often missed by routine testing. The approach has resulted in a 4% increase in new HIV diagnoses in North Carolina and has shown promise for reducing transmission and saving lives.
A study published in Science suggests that proteins normally pass into the kidneys and that kidney disease may result from an inability to draw them back out. Researchers identified at least two patients with kidney disease who lack one copy of CD2AP, a protein critical for kidney function.
Researchers have developed an antibody-coated stent that reduces restenosis and prevents blood clots, leading to improved cardiovascular treatment outcomes. The device captures endothelial progenitor cells to promote healing and prevent re-narrowing of the artery.
A new study found that antibodies in female mice attached to their babies' cells stimulate a T-cell response, leading to ovarian destruction and inflammation. The researchers suggest that exposure to the mother's antibody during critical periods of development is crucial for avoiding autoimmune disease.
Researchers found that small toxic molecules triggering cell damage in degenerative diseases have a similar structure. This discovery implies that these molecules are suitable targets for new drugs or vaccines that could halt progression of many degenerative diseases.
The study reveals how B cell lymphocytes assemble genes to encode specific classes of antibodies, including IgA, IgE, and IgG. The findings also explain the role of activation-induced cytidine deaminase (AID) in initiating gene specialization, a process crucial for the immune response.
Researchers found that even a moderate loss of fat leads to decreased amounts of infection-fighting IgG antibodies, increasing disease susceptibility. Immune system function improved after regrowth of removed fat tissue.
Researchers have combined an antibody with an antioxidant enzyme to protect transplanted lungs from oxidative stress, improving lung-graft survivability and storage time. The anti-PECAM/catalase hybrid construct strengthened antioxidant defenses and reduced free-radical damage in animal models.
A new spice-like substance, made from freeze-dried egg yolk, shows promise in preventing foodborne illnesses. The antibody-based compound can remain active for up to two hours after ingestion, providing precious time to seek medical attention.
A new anti-IgE antibody has shown promise in preventing severe allergic reactions to peanuts. The treatment increased patients' threshold sensitivity to peanut flour, allowing them to consume more without a reaction.
Researchers at Scripps Research Institute have found that the human body produces ozone as part of a mechanism to protect itself from bacteria and fungi. The discovery suggests a new role for neutrophils and antibodies in the immune system, potentially leading to new treatments for inflammatory diseases.
Researchers at Rockefeller University reveal a crucial link between the Ezh2 protein and chromatin modifications, enabling the development of a wide range of antibodies. The discovery provides new insights into B cell biology and the immune system.
A new antibody library developed by PNNL scientists can identify antibodies in days, reducing labor costs and improving the design of medical treatments. The library, which contains 1 billion human antibodies, uses a yeast surface display method to quickly screen for useful antibodies.
Researchers create a new, cost-effective way to produce human therapeutic proteins using algae. They can now make large quantities of antibodies and other proteins much cheaper than traditional methods.
Research reveals that mice without the calcitonin gene exhibit greater bone mass and formation, suggesting a novel function for this hormone. This discovery opens up new avenues for preventing bone loss associated with estrogen deficiency.
Scientists have developed a way to measure protein flexibility using lasers, revealing a dynamic process in antibody-antigen recognition. The technique allows for the detection of rapid molecular motions, suggesting that antigen recognition may not be a simple lock-and-key mechanism.
Researchers discovered that a high level of perceived life stress was associated with low antibody levels in students after receiving the meningitis C vaccine. Low psychological well-being, such as feeling anxious or under strain, was also linked to low antibody levels.
Researchers found that patients with advanced prostate cancer treated with zoledronic acid experienced fewer bone complications and less pain compared to those who received a placebo. Additionally, tumors in patients treated with the HuMV833 antiangiogenic antibody showed marked differences in antibody uptake, distribution, and clearance.
Researchers at Johns Hopkins Medicine developed a new technique using plasmapheresis and immunosuppressive medication to prevent antibody production against donor organs. The treatment resulted in an average of 13-month-long protection against organ rejection, significantly reducing long-term complications.
Researchers at the University of Illinois have developed a new molecular imprinting process to create artificial antibodies. The technique involves imprinting a single molecule within a highly branched polymer called a dendrimer, allowing for specific binding and rejection of target molecules. This breakthrough has potential applicatio...
A vaccine has been shown to delay symptoms of prion brain disease in mice by inducing an immune response and producing antibodies. This breakthrough could potentially lead to a therapeutic response and prevent the disease in animals at risk.
Researchers created antibodies that recognize and attach to cancer-fighting drug molecules, separating them from unwanted compounds. The 'smart membrane' technology could replace expensive chromatography methods, promising faster and more efficient drug production within five to 10 years.
Researchers at the University of Pittsburgh's McGowan Institute for Regenerative Medicine have made significant breakthroughs in regenerative medicine. Filtering antibodies from blood may decrease the risk of organ rejection, with experiments showing a 40-60% reduction when coated with specific antigens. Additionally, injecting drag-re...
The company's phase I clinical trial will examine NicVAX's safety and ability to stimulate the immune system in nonsmokers. If successful, additional trials will be conducted to investigate its efficacy in smokers and ex-smokers.
As bodies age, B cells lose potency due to accumulation of antigen-experienced cells. These cells, which were initially effective against previous infections, become less responsive and bind weakly to new pathogens.
Researchers at Princeton University have pinpointed what appears to be a central cause of lupus, an autoimmune disease that affects 1.4 million Americans. The discovery highlights a specific mechanism in B cells that produces disease-fighting antibodies, which can mistakenly attack the body's own DNA.
A new study reveals that patients with gluten sensitivity may experience neurological dysfunction without gastrointestinal symptoms. The research found antibodies against Purkinje cells and cross-reacting antibodies against gluten, suggesting a potential link between gluten consumption and brain damage.
Scientists at Scripps Research Institute have identified human antibodies that can recognize spore surfaces, enabling the detection of anthrax and other bacterial spores. These antibodies could be used to passively immunize individuals exposed to anthrax, providing a simple and inexpensive treatment option.
A simple immunochromatographic assay detected specific antibodies in the blood of untreated coeliac patients, with high accuracy and speed. The test can be done in a doctor's surgery and is useful for screening patients with untypical symptoms or risk factors for coeliac disease.
Researchers have created a new vaccine that can prevent life-threatening infections caused by Staphylococcus aureus bacteria, which are resistant to common antibiotics. The vaccine targets the bacteria's capsular polysaccharides and has shown significant efficacy in reducing bacteremia in hemodialysis patients.
The Nabi experimental vaccine reduced bloodstream infections caused by Staphylococcus aureus in end-stage kidney disease patients by nearly 60%. The vaccine elicited a significant antibody response in 86% of the patients, and significantly reduced the incidence of systemic S. aureus infection in the blood.
Researchers from Brown University and Seattle Biomedical Research Institute found high antibody levels against liver stage antigens (LSAs) correlate with malaria resistance. The study suggests LSAs may stimulate an immune response that protects against infection, paving the way for new malaria vaccine strategies.
Researchers found a virus similar to HEV in rats in Los Angeles, which may contribute to the high rates of HEV antibodies in some inner city areas. The study suggests that infected rats could be a source of exposure for humans and highlights the need for further testing.
Researchers found that bovine thrombin causes an immune response similar to lupus in mice and can lead to post-operative complications. Bovine thrombin is a potent enzyme used in surgical procedures, but its use should be restricted to life-saving surgeries due to the risk of autoimmune responses.
Researchers found a link between higher levels of antibodies neutralizing toxins and better kidney function in patients after heart surgery. The study suggests potential interventions to protect kidneys from endotoxins released by bacteria during surgery.
Researchers found that antibodies can convert oxygen into hydrogen peroxide, a previously unknown mechanism that could enhance their killing power and contribute to autoimmune diseases like lupus. This discovery opens up exciting possibilities for new antibody-mediated therapies for bacterial, viral, and cancer treatments.
Researchers at UC Berkeley have developed a sensitive assay for detecting proteins associated with prostate cancer, which could lead to fast screening and molecular profiling for various diseases. The technique uses micromachined cantilevers that can detect levels of protein markers 20 times lower than the clinically relevant threshold.
Researchers create antibody Fab D18, which blocks prion propagation and clears infectious prions from cell cultures. This breakthrough provides a potential therapeutic target for a human drug to cure established infection.
Vancouver is facing a high risk of an hepatitis A outbreak due to past infections among street youth, injection drug users, and men who have sex with men. The Canadian Medical Association Journal report highlights the need for vaccination programs to protect these groups.